Skip to content
Citation only via OpenAlex

Rapamycin enhances lifespan: At last, an advantage for transplant recipients?

Edward Kenneth Geissler

Nephrology Dialysis Transplantation · 2009 · ▲ 2 citations

Abstract

A recently published article by Harrison and colleagues [ 1 ] confirms in mammals what has been known for several years in yeast, fruitflies and nematodes: the TOR inhibitor mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) extends lifespan. These extraordinary experiments were performed through The National Institute on Aging and Interventions Testing Program , which uses rigorous testing methods in genetically heterogeneous mice at three separate test sites to determine if ageing and lifespan are increased by specific agents. Remarkably, continuous rapamycin treatment extended not only the median life- span in mice, but maximal lifespan was also significantly increased. Extended median and maximal lifespan were clearly evident at all three test sites in both female and male mice, and were generally on the order of a 10% or better improvement. Moreover, enhanced lifespan was demonstrated where feeding of rapamycin was initiated at either 270 or 600 days of age, suggesting that mid-life or late intervention has a positive effect, with no evidence for altered disease patterns. Compared to other interventions aimed at increasing life expectancy in rodents, the rapamycin effect is impressively strong and worthy of further exploration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/ndt/gfp496
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Geissler, E.K. (2009). Rapamycin enhances lifespan: At last, an advantage for transplant recipients?. <em>Nephrology Dialysis Transplantation</em>. https://doi.org/10.1093/ndt/gfp496
Vancouver
Geissler EK. Rapamycin enhances lifespan: At last, an advantage for transplant recipients?. Nephrology Dialysis Transplantation. 2009. doi:10.1093/ndt/gfp496.
BibTeX
@article{edward2009Rapamy, title = {Rapamycin enhances lifespan: At last, an advantage for transplant recipients?}, author = {Edward Kenneth Geissler}, journal = {Nephrology Dialysis Transplantation}, year = {2009}, doi = {10.1093/ndt/gfp496}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings